sales@starshinechemical.com
CAS RN: 25316-40-9
Doxorubicin Hydrochloride
- Product code: ICTD4193
- Purity/Analytical Methods: >95.0%(HPLC)
Basic Information
| Appearance and Shape (20°C) | Solid |
|---|---|
| CAS RN | 25316-40-9 |
| MDL number | MFCD00077757 |
| Molecular weight | 579.98 |
| Molecular Formula | C27H29NO11·HCl |
| Product code | ICTD4193 |
| PubChem Substance ID | 253660149 |
| Purity/Analytical Methods | >95.0%(HPLC) |
| Reaxys-RN | 4229251 |
| Situations to avoid | Light Sensitive,Heat Sensitive |
Technical Specifications
Technical Specifications
| Appearance | Light yellow to Brown powder to crystal |
|---|
Safety and Regulatory
GHS
| Pictograms |
|
|---|---|
| Hazard statement | H302 : Harmful if swallowed H361 : Suspected of damaging fertility or the unborn child H373 : May cause damage to organs through prolonged or repeated exposure H351 : Suspected of causing cancer. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant P260 : Do not breathe dust/ fume/ gas/ mist/ vapors/ spray P270 : Do not eat, drink or smoke when using this product P202 : Do not handle until all safety precautions have been read and understood P201 : Obtain special instructions before use P264 : Wash skin thoroughly after handling P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection P308 + P313 : IF exposed or concerned: Get medical advice/ attention P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth P405 : Store locked up. |
| Signal word | Warning |
Related legislation
| RTECS# | QI9295900 |
|---|
Product Category
Chemical structure
Chemistry Chemical Biology Glycoscience Applications Using Glyco-materials Vaccine [Application Using Glyco-materials] Vaccine Adjuvant [Application Using Glyco-materials] Glyco-engeneering [Application Using Glyco-materials] Glyco-utilization [Application Using Glyco-materials] Other Sugars [Glycoscience] Pharmaceutical Development and Drug Discovery Research Reagents Reagents for Antibody-Drug Conjugates (ADC) Preparation Research Payload (Drug) Candidates [ADC Preparation Research Reagents]
Life Science Biochemicals and Reagents Animal Disease Models Preparation Reagents for Central Nervous System Disease Models Reagents for Inflammation & Immunity Disorder Models Reagents for Life-style related Disease Models Antibiotics Antibiotics (Chemical Structure Class) Tetracycline Antibiotics (for Research and Experimental Use) Enzymes, Enzyme Inhibitors, Enzyme Substrates Enzyme Inhibitors [Biochemicals and Reagents] Enzyme Inhibitors [D to K] Cytochrome P450 (CYP1A1) Inhibitors, DNA Topoisomerase II Inhibitors Enzyme Inhibitors [R to Z] Topoisomerase II Inhibitors Enzyme Inhibitors by Enzyme Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Antibiotics Antitumor Ingredients (for Research and Experimental Use) Cell Biology Cancer Research Antitumor Agents DNA-RNA Transcription Regulators Topoisomerase Inhibitors Stem Cell Biology Regenerative Medicine Research Reagents Glycoscience Applications Using Glyco-materials Glyco-engeneering [Application Using Glyco-materials] Glyco-utilization [Application Using Glyco-materials] Vaccine [Application Using Glyco-materials] Vaccine Adjuvant [Application Using Glyco-materials] Other Sugars [Glycoscience] Molecular Biology Regenerative Medicine Research Reagents Pharmaceutical Development and Drug Discovery Research Antibiotics Antibiotics (Chemical Structure Class) Tetracycline Antibiotics (for Research and Experimental Use) Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Antibiotics Antitumor Ingredients (for Research and Experimental Use) Reagents for Antibody-Drug Conjugates (ADC) Preparation Research Payload (Drug) Candidates [ADC Preparation Research Reagents]